By Fineline Cube 
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, HKG: 2607, SHA: 601607) announced the signing of a strategic cooperation agreement with Baxter China. The partnership aims to expand and deepen collaboration on high-quality imported medical products, with a particular focus on the anesthesia field.
Collaboration Background
Baxter and Shanghai Pharma have previously established a strong foundation for cooperation. Through this new strategic agreement, both parties will leverage Shanghai Pharma’s extensive market coverage and distribution channels to enhance the accessibility of Baxter’s anesthesia products in China.
Future Collaboration
Looking ahead, the two companies plan to strengthen their collaboration and explore synergistic opportunities in various areas. These include the commercialization of innovative drugs, the establishment of specialty pharmacies, and the development of patient support programs.-Fineline Info & Tech